Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant CyclophosphamideAsad Bashey, Mary Eapen, Rizwan Romee et al.|Journal of Clinical Oncology|2017Cited by 325
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamideShannon R. McCurdy, Yvette L. Kasamon, Jennifer A. Kanakry et al.|Blood|2015Cited by 299
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamideShannon R. McCurdy, Leo Luznik, Yvette L. Kasamon et al.|Haematologica|2016Cited by 187
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R. McCurdy, Leo Luznik, Vedran Radojčić et al.|Blood|2021Cited by 100
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamideShannon R. McCurdy, Mary Eapen, Mei-Jie Zhang et al.|Blood Advances|2018Cited by 96